FDA approves MR-conditioning labeling for Abbott’s pacemaker
The FDA approved a magnetic resonance (MR)-conditioning labeling for Abbott’s Assurity MRI pacemaker and its Tendreil MRI pacing lead.
Abbott announced the approval in a news release on Feb. 1.
Patients implanted with the devices can now undergo full-body MRI scans. The company also mentioned the Assurity MRI pacemaker offers wireless remote monitoring.
Abbott said it plans on seeking more MR-conditioning labeling for its pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices.
St. Jude Medical developed the Assurity MRI pacemaker. On Jan. 4, Abbott completed its acquisition of St. Jude Medical for approximately $25 billion.